EUVIMEDEUVIMED entdecken
Crossref

Post COVID-19 vaccine Guillain Barre Syndrome

Soban Khan, Maryam Khalil, Zaid Waqar, Sajid Khan, Zakir Jan

Pakistan Journal of Neurological Sciences · 2022

DOI: 10.56310/pjns.v17i02.174 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Pakistan Journal of Neurological Sciences, 2022. Verfasst von Soban Khan und 4 weiteren Autor:innen.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The Guillain Barre Syndrome (GBS) is an acute immune mediated progressive polyneuropathy having an acute monophasic illness leading to paralysis. The clinical features are progressive ascending symmetrical muscle weakness that may lead to respiratory failure. Diagnosis is based upon clinical presentation and is supported by a lumbar puncture with CSF analysis demonstrating albumin cytological dissociation and electrophysiological studies. Our patient presented to us with progressive ascending paralysis after receiving COVID 19 vaccine.

Zitieren

APA

Khan, S., Khalil, M., Waqar, Z., Khan, S., & Jan, Z. (2022). Post COVID-19 vaccine Guillain Barre Syndrome. Pakistan Journal of Neurological Sciences. https://doi.org/10.56310/pjns.v17i02.174

Vancouver

Khan S, Khalil M, Waqar Z, Khan S, Jan Z. Post COVID-19 vaccine Guillain Barre Syndrome. Pakistan Journal of Neurological Sciences. 2022. doi:10.56310/pjns.v17i02.174

BibTeX
@article{Khan2022,
  author = {Khan, Soban and Khalil, Maryam and Waqar, Zaid and Khan, Sajid and Jan, Zakir},
  title = {Post COVID-19 vaccine Guillain Barre Syndrome},
  journal = {Pakistan Journal of Neurological Sciences},
  year = {2022},
  doi = {10.56310/pjns.v17i02.174}
}
Kostenlos starten →